{
    "2020-12-02": [
        [
            {
                "time": "",
                "original_text": "乐普医疗分拆全资子公司乐普诊断科创板IPO，疫情下业绩暴增难掩母公司销售渠道依赖隐忧",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "分拆",
                        "乐普诊断",
                        "科创板",
                        "IPO",
                        "疫情",
                        "业绩暴增",
                        "销售渠道依赖"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【浙商医药|周报】把握中国优势，就是把握明年行情",
                "features": {
                    "keywords": [
                        "浙商医药",
                        "周报",
                        "中国优势",
                        "行情"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "乐普医疗(300003.SZ)：氯沙坦钾氢氯噻嗪片通过药品一致性评价",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "氯沙坦钾氢氯噻嗪片",
                        "药品一致性评价"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "浦江国际（2060.HK）: 估值处于历史低位，具备更大的修复潜能",
                "features": {
                    "keywords": [
                        "浦江国际",
                        "估值",
                        "历史低位",
                        "修复潜能"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "近日药闻：乐普医疗子公司拟上市科创板，中国生物制药“纳尔复”过评",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "子公司",
                        "科创板",
                        "中国生物制药",
                        "纳尔复",
                        "过评"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "科创板IPO | 乐普医疗“送子赴考”，业绩“偶发性”增长后，乐普诊断路在何方?",
                "features": {
                    "keywords": [
                        "科创板",
                        "IPO",
                        "乐普医疗",
                        "乐普诊断",
                        "业绩增长",
                        "偶发性"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【浙商医药|点评】器械创新方兴未艾，多领域孕育投资机会",
                "features": {
                    "keywords": [
                        "浙商医药",
                        "器械创新",
                        "投资机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【浙商医药|周报】如何选股？创新赋能、制造升级和降本增效",
                "features": {
                    "keywords": [
                        "浙商医药",
                        "选股",
                        "创新赋能",
                        "制造升级",
                        "降本增效"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "乐普诊断被分拆赴科创板上市净利润排同行尾部独立后能否“断奶”？",
                "features": {
                    "keywords": [
                        "乐普诊断",
                        "分拆",
                        "科创板",
                        "净利润",
                        "同行尾部",
                        "断奶"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "29家公司高管出手增持动用资金1.09亿元",
                "features": {
                    "keywords": [
                        "公司高管",
                        "增持",
                        "资金",
                        "1.09亿元"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}